This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Follow-up and monitoring if confirmed endometriosis

Authoring team

NICE state (1):

  • Monitoring for women with confirmed endometriosis
    • consider outpatient follow-up (with or without examination and pelvic imaging) for women with confirmed endometriosis, particularly women who choose not to have surgery, if they have:
      • deep endometriosis involving the bowel, bladder or ureter or
      • 1 or more endometrioma that is larger than 3 cm

Notes:

  • Medical treatment:
    • medical treatment is generally effective at treating pain e.g. secondary dyspareunia, especially if only minimal disease. However about 40% of women will have a recurrence of symptoms at some time after cessation of treatment
  • Surgical treatment:
    • if surgical treatment is adequate then the recurrence rate is less than 20%. Improvement in fertility is related to severity of disease. The conception rate after treatment for severe disease is about 35%; whilst a 65% conception rate has been reported after treatment for moderate disease. The chance of conception is greatest in the two years following surgery
  • if a patient has had a total abdominal hysterectomy, bilateral salpingoophrectomy and resection of other deposits of endometriosis, then hormone replacement therapy can be used with a minimal risk of growth in any residual endometriosis

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.